<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2020.104092</article-id><article-id pub-id-type="publisher-id">ACM-35273</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20200400000_47611089.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  胎龄 &lt; 32周早产儿支气管肺发育不良临床危险因素及并发症的分析与防治策略
  Analysis ofClinical Risk Factors, Complications and Prevention Strategies for Bronchopulmonary Dysplasia in Preterm Infants with Gestational Age &lt; 32 Weeks
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>李</surname><given-names>丽丽</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>李</surname><given-names>瑞</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>曾</surname><given-names>月瑶</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>刘</surname><given-names>冬云</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>青岛大学附属医院儿科，山东 青岛</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>10</day><month>04</month><year>2020</year></pub-date><volume>10</volume><issue>04</issue><fpage>587</fpage><lpage>594</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  目的：探讨胎龄 &lt; 32周早产儿支气管肺发育不良(bronchopulmonary dysplasia, BPD)的临床危险因素，探寻早产儿发生BPD的防治策略以及综合管理措施。方法：回顾性调查2016年1月至2018年10月期间于青岛大学附属医院新生儿重症监护室(NICU)住院的胎龄 &lt; 32周532例早产儿的临床资料，按BPD的诊断标准分为BPD组(病例组，共134例)和非BPD组(对照组，共398例)，对两组临床资料进行对比分析。结果：本研究BPD发生率为25.2%，其发生与IVF-ET、顺产、胎膜早破 &gt; 18 h、羊水污染、胎龄、出生体重、1分钟Apgar评分、5分钟Apgar评分、单剂PS应用、多剂PS应用、侵入性有创机械通气时间、无创通气时间、面罩/鼻导管吸氧时间、吸入氧浓度 ≥ 30%、输血和输血次数等因素相关(P均&lt;0.05)；BPD与新生儿肺炎、败血症、NRDS、PDA、早产儿脑损伤、ROP、代谢性骨病、胆汁淤积、肺动脉高压等疾病有统计学关联(P均&lt;0.05)。结论：避免早产、减少孕母产前感染及早产儿生后感染、缩短机械通气和用氧时间、降低用氧浓度和积极防治并发症，以期预防BPD的发生并改善预后。
   Objective: To explore the clinical risk factors of bronchopulmonary dysplasia in preterm infants with gestational age &lt; 32 weeks, and to seek the strategies and comprehensive management measures for prevening or treating BPD. Methods: Retrospective investigation of clinical data of 532 preterm infants with gestational age of &lt;32 weeks who were admitted to the neonatal intensive care unit (NICU) of the Affiliated Hospital of Qingdao University from June 2016 to October 2018. They were divided into BPD groups according to the diagnostic criteria of BPD (case Group, total 134 patients) and non-BPD group (control group, total 398 patients), then, compared and analyzed the clinical risk factors of the two groups. Results: The incidence of BPD in this study was 25.2%. And the IVF-ET, normal labor, premature rupture of membranes &gt; 18 h, amniotic fluid pollution, gestational age, birth weight, 1-minute Apgar score, 5-minute Apgar score, single-dose PS application, multiple-dose PS application, invasive mechanical ventilation time, non-invasive ventilation Time, mask/nasal catheter oxygen inhalation time, inhaled oxygen concentration ≥ 40%, blood transfusion and blood transfusion times and other factors were the related risk factors of BPD (all P &lt; 0.05). BPD was statistically associated with neonatal pneumonia, sepsis, NRDS, PDA, brain injury in preterm infants, ROP, metabolic bone disease, cholestasis, pulmonary hypertension (all P &lt; 0.05). Conclusion: In order to prevent preterm infants with gestational age &lt; 32 weeks frome BPD and improve the prognosis, we need to avoid preterm birth, reduce pregnant women prenatal infections and preterm infants infections, shorten mechanical ventilation and use oxygen time, reduce oxygen concentration and actively prevent and treat complications. 
  
 
</p></abstract><kwd-group><kwd>早产儿，支气管肺发育不良，高危因素，并发症，防治策略, Premature Infants</kwd><kwd>
Bronchopulmonary Dysplasia</kwd><kwd> High Rrisk Factors</kwd><kwd> Complication</kwd><kwd> Prevention
Strategies</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>胎龄 &lt; 32周早产儿支气管肺发育不良临床危险因素及并发症的分析与防治策略<sup> </sup></title><p>李丽丽<sup>1,2</sup>，李瑞<sup>1,2</sup>，曾月瑶<sup>1,2</sup>，刘冬云<sup>1*</sup></p><p><sup>1</sup>青岛大学附属医院儿科，山东 青岛</p><p><sup>2</sup>青岛大学，山东 青岛</p><disp-formula id="hanspub.35273-formula35"><graphic xlink:href="//html.hanspub.org/file/19-1571258x5_hanspub.png"  xlink:type="simple"/></disp-formula><p>收稿日期：2020年4月4日；录用日期：2020年4月19日；发布日期：2020年4月26日</p><disp-formula id="hanspub.35273-formula36"><graphic xlink:href="//html.hanspub.org/file/19-1571258x6_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2"><title>摘 要</title><p>目的：探讨胎龄 &lt; 32周早产儿支气管肺发育不良(bronchopulmonary dysplasia, BPD)的临床危险因素，探寻早产儿发生BPD的防治策略以及综合管理措施。方法：回顾性调查2016年1月至2018年10月期间于青岛大学附属医院新生儿重症监护室(NICU)住院的胎龄 &lt; 32周532例早产儿的临床资料，按BPD的诊断标准分为BPD组(病例组，共134例)和非BPD组(对照组，共398例)，对两组临床资料进行对比分析。结果：本研究BPD发生率为25.2%，其发生与IVF-ET、顺产、胎膜早破 &gt; 18 h、羊水污染、胎龄、出生体重、1分钟Apgar评分、5分钟Apgar评分、单剂PS应用、多剂PS应用、侵入性有创机械通气时间、无创通气时间、面罩/鼻导管吸氧时间、吸入氧浓度 ≥ 30%、输血和输血次数等因素相关(P均&lt;0.05)；BPD与新生儿肺炎、败血症、NRDS、PDA、早产儿脑损伤、ROP、代谢性骨病、胆汁淤积、肺动脉高压等疾病有统计学关联(P均&lt;0.05)。结论：避免早产、减少孕母产前感染及早产儿生后感染、缩短机械通气和用氧时间、降低用氧浓度和积极防治并发症，以期预防BPD的发生并改善预后。</p><p>关键词 :早产儿，支气管肺发育不良，高危因素，并发症，防治策略</p><disp-formula id="hanspub.35273-formula37"><graphic xlink:href="//html.hanspub.org/file/19-1571258x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2020 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/19-1571258x8_hanspub.png" /> <img src="//html.hanspub.org/file/19-1571258x9_hanspub.png" /></p></sec><sec id="s3"><title>1. 引言</title><p>早产儿支气管肺发育不良(bronchopulmonary dysplasia, BPD)是好发于早产儿的慢性呼吸系统常见疾病，具有独特的临床、影像学及组织学特征，又称为新生儿慢性肺病(neonatal chronic lung disease, CLD)。近年来，虽然围产医学和早产儿生后呼吸管理策略有了长足的发展与进步，但BPD的发生仍是影响早产儿预后和生后质量的一个持续存在的问题 [<xref ref-type="bibr" rid="hanspub.35273-ref1">1</xref>]。患儿有BPD的早产儿不仅住院时间长、生长发育迟缓，出院后还常因反复上呼吸道感染、肺炎以及喘息性肺病等疾病再住院。Dandan Chen等研究认为，BPD的严重程度与呼吸系统的不良预后相关 [<xref ref-type="bibr" rid="hanspub.35273-ref1">1</xref>] [<xref ref-type="bibr" rid="hanspub.35273-ref2">2</xref>]。而且，Sillers L. [<xref ref-type="bibr" rid="hanspub.35273-ref3">3</xref>] 等认为与非BPD早产儿相比，有BPD病史的年长儿童和青少年的平均肺功能状态和生活质量相似但肺功能障碍持续存在，而且在成年期间对早期发作的慢性阻塞性肺疾病的易感性增加。因此，探索早产儿BPD发生的临床高危因素，积极防治以降低早产儿BPD的发病率和改善BPD早产儿预后至关重要。</p></sec><sec id="s4"><title>2. 研究对象与方法</title><sec id="s4_1"><title>2.1. 研究对象</title><p>2016年1月至2018年10月期间于青岛大学附属医院新生儿重症监护室(NICU)入院胎龄 &lt; 32周及住院时间 ≥ 28天的早产儿共532例，其中BPD组(病例组) 134例，男性72例，女性62例；非BPD组(对照组) 398例，男性179例，女性219例。本项临床研究为回顾性研究，仅采集患者临床资料，不干预患者治疗方案，不会对患者生理带来风险，经青岛大学附属医院医学伦理委员会同意后免除签署知情同意，且为保护患者隐私外泄隐藏患者姓名及住院号。</p></sec><sec id="s4_2"><title>2.2. 研究方法</title><sec id="s4_2_1"><title>2.2.1. 纳入与排除标准</title><p>BPD的诊断标准：参照2018年美国国家儿童健康与人类发展研究所(NICHD) 2016年10月通过的BPD诊断标准 [<xref ref-type="bibr" rid="hanspub.35273-ref4">4</xref>]；排除标准：除外患有严重心脏病、肺出血、气胸、先天性胸廓畸形、膈疝、外科手术、先天性畸形和患有遗传代谢性疾病影响BPD诊断的疾病，以及住院时间不满28天、临床资料收集不完整者。</p></sec><sec id="s4_2_2"><title>2.2.2. 本研究临床观察项目</title><p>回顾性调查统计所有研究对象以下几个方面的临床资料：1) 胎儿因素：性别，胎龄，出生体重，1分钟Apgar评分和5分钟Apgar评分，多胎妊娠；2) 孕母产前因素：胎次、受孕方式、分娩方式、是否双胎或多胎；是否有胎膜早破 &gt; 18 h、妊娠期糖尿病、妊娠期高血压、胎儿宫内窘迫和产前激素应用史；3) 治疗因素：生后肺表面活性物质(PS)应用，用氧时间和用氧方式(有创机械通气、无创机械通气、面罩吸氧/鼻导管吸氧等)，用氧浓度 ≥ 30%，总住院时间；4) 并发症发生情况：生后感染(肺炎、败血症等)、新生儿坏死性小肠结肠炎(neonatal necrotizing enterocolitis, NEC)、新生儿呼吸窘迫综合征(neonatal respiratory distress syndrome, NRDS)、贫血、动脉导管未闭(patent ductus arteriosus, PDA)、肺动脉高压、早产儿脑损伤、早产儿视网膜病变(retinopathy of prematurity, ROP)、胆汁淤积、代谢性骨病等疾病发生情况。</p></sec></sec><sec id="s4_3"><title>2.3. 统计学分析</title><p>采用SPSS 24.0软件进行数据分析，定量资料以 x &#175; &#177; s表示，组间比较采用t检验；计数资料采用χ<sup>2</sup>检验。以P &lt; 0.05为差异有统计学意义。</p></sec></sec><sec id="s5"><title>3. 结果</title><sec id="s5_1"><title>3.1. BPD组与非BPD组孕母产前临床因素分析</title><p>孕母产前情况比较发现：受孕方式、分娩方式、胎膜早破 &gt; 18 h、羊水污染等因素与BPD的发生相关(P均&lt;0.05)；而孕母年龄、妊娠期高血压、妊娠期糖尿病及产前激素的应用等因素与早产儿BPD的发生无统计学关联(P均&gt;0.05)；见表1。</p></sec><sec id="s5_2"><title>3.2. BPD组与非BPD组早产儿围生期因素和住院期间治疗因素临床资料分析</title><p>围生期资料比较表明：BPD的发生与1分钟Apgar评分、5分钟Apgar评分相关(P均&lt;0.05)，而与性别、多胎无关(P &gt; 0.05)；住院期间治疗因素比较表明：BPD的发生与单剂PS应用、多剂PS应用、侵入性有创机械通气时间、无创通气时间、面罩/鼻导管吸氧时间、吸入氧浓度 ≥ 30%、输血和输血次数、住院期间体质量每日增长均具有统计学关联(P均&lt;0.05)，且比非BPD早产儿总住院时间长(P &lt; 0.05)；见表2。</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Comparison of prenatal clinical factors of pregnant women in BPD group and non-BPD grou</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >项目</th><th align="center" valign="middle"  colspan="2"  ></th><th align="center" valign="middle" >例数</th><th align="center" valign="middle" >BPD组</th><th align="center" valign="middle" >非BPD组</th><th align="center" valign="middle" >t/χ<sup>2</sup></th><th align="center" valign="middle" >P</th></tr></thead><tr><td align="center" valign="middle"  colspan="3"  >孕母年龄(岁， x &#175; &#177; s )</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >32.72 &#177; 4.76</td><td align="center" valign="middle" >33.62 &#177; 5.21</td><td align="center" valign="middle" >1.756</td><td align="center" valign="middle" >0.080</td></tr><tr><td align="center" valign="middle"  colspan="2"   rowspan="2"  >受孕方式，n (%)</td><td align="center" valign="middle" >IVF-ET*</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" >26 (13.1)</td><td align="center" valign="middle" >26 (6.5)</td><td align="center" valign="middle"  rowspan="2"  >11.304</td><td align="center" valign="middle"  rowspan="2"  >&lt;0.001</td></tr><tr><td align="center" valign="middle" >自然受孕</td><td align="center" valign="middle" >480</td><td align="center" valign="middle" >108 (80.6)</td><td align="center" valign="middle" >372 (93.5)</td></tr><tr><td align="center" valign="middle"  colspan="2"   rowspan="2"  >分娩方式，n (%)</td><td align="center" valign="middle" >剖宫产</td><td align="center" valign="middle" >391</td><td align="center" valign="middle" >85 (63.4)</td><td align="center" valign="middle" >306 (76.9)</td><td align="center" valign="middle"  rowspan="2"  >9.312</td><td align="center" valign="middle"  rowspan="2"  >0.002</td></tr><tr><td align="center" valign="middle" >顺产</td><td align="center" valign="middle" >141</td><td align="center" valign="middle" >49 (36.6)</td><td align="center" valign="middle" >92 (23.1)</td></tr><tr><td align="center" valign="middle"  colspan="3"  >妊娠期高血压，n (%)</td><td align="center" valign="middle" >208</td><td align="center" valign="middle" >55 (41.0)</td><td align="center" valign="middle" >153 (38.4)</td><td align="center" valign="middle" >0.285</td><td align="center" valign="middle" >0.593</td></tr><tr><td align="center" valign="middle"  colspan="3"  >妊娠期糖尿病，n (%)</td><td align="center" valign="middle" >86</td><td align="center" valign="middle" >23 (17.2)</td><td align="center" valign="middle" >63 (15.8)</td><td align="center" valign="middle" >0.132</td><td align="center" valign="middle" >0.717</td></tr><tr><td align="center" valign="middle"  colspan="3"  >胎膜早破 &gt; 18 h，n (%)</td><td align="center" valign="middle" >150</td><td align="center" valign="middle" >49 (36.6)</td><td align="center" valign="middle" >101 (25.4)</td><td align="center" valign="middle" >6.201</td><td align="center" valign="middle" >0.013</td></tr><tr><td align="center" valign="middle"  colspan="3"  >宫内窘迫，n (%)</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >7 (5.2)</td><td align="center" valign="middle" >27 (6.8)</td><td align="center" valign="middle" >0.408</td><td align="center" valign="middle" >0.523</td></tr><tr><td align="center" valign="middle"  colspan="3"  >羊水污染，n (%)</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >16 (11.9)</td><td align="center" valign="middle" >19 (4.8)</td><td align="center" valign="middle" >8.377</td><td align="center" valign="middle" >0.004</td></tr><tr><td align="center" valign="middle"  colspan="3"  >产前激素，n (%)</td><td align="center" valign="middle" >373</td><td align="center" valign="middle" >90 (67.2)</td><td align="center" valign="middle" >283 (71.1)</td><td align="center" valign="middle" >0.743</td><td align="center" valign="middle" >0.389</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>表1. BPD组与非BPD组孕母产前临床因素比较</p><p>注：<sup>*</sup>IVF-ET：胚胎-移植术。</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Comparison of perinatal clinical data of preterm infants in BPD group and non-BPD grou</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >项目</th><th align="center" valign="middle" >BPD组</th><th align="center" valign="middle" >非BPD组</th><th align="center" valign="middle" >χ<sup>2</sup>/Z</th><th align="center" valign="middle" >P</th></tr></thead><tr><td align="center" valign="middle" >性别，男(n,%)</td><td align="center" valign="middle" >72 (53.7)</td><td align="center" valign="middle" >179 (45.0)</td><td align="center" valign="middle" >3.084</td><td align="center" valign="middle" >0.079</td></tr><tr><td align="center" valign="middle" >胎龄(w, x &#175; &#177; s )</td><td align="center" valign="middle" >28.63 &#177; 1.71</td><td align="center" valign="middle" >30.18 &#177; 1.26</td><td align="center" valign="middle" >9.652</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >出生体重(g, x &#175; &#177; s )</td><td align="center" valign="middle" >1070.51 &#177; 253.38</td><td align="center" valign="middle" >1330.18 &#177; 262.61</td><td align="center" valign="middle" >9.987</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >多胎(n, %)</td><td align="center" valign="middle" >31 (23.1)</td><td align="center" valign="middle" >72 (18.1)</td><td align="center" valign="middle" >1.634</td><td align="center" valign="middle" >0.201</td></tr><tr><td align="center" valign="middle" >1分钟Apgar评分(分， x &#175; &#177; s )</td><td align="center" valign="middle" >6.46 &#177; 2.36</td><td align="center" valign="middle" >7.72 &#177; 2.06</td><td align="center" valign="middle" >5.553</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >5分钟Apgar评分(分， x &#175; &#177; s )</td><td align="center" valign="middle" >8.11 &#177; 1.87</td><td align="center" valign="middle" >9.09 &#177; 1.38</td><td align="center" valign="middle" >5.524</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >单剂PS*应用(n, %)</td><td align="center" valign="middle" >52 (38.8)</td><td align="center" valign="middle" >74 (18.6)</td><td align="center" valign="middle" >22.660</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >多剂PS*应用(n, %)</td><td align="center" valign="middle" >20 (14.9)</td><td align="center" valign="middle" >8 (2.0)</td><td align="center" valign="middle" >33.537</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >侵入性有创机械通气时间(d, x &#175; &#177; s )</td><td align="center" valign="middle" >2.22 &#177; 8.27</td><td align="center" valign="middle" >0.13 &#177; 0.78</td><td align="center" valign="middle" >−2.920</td><td align="center" valign="middle" >0.004</td></tr><tr><td align="center" valign="middle" >无创机械通气时间(d, x &#175; &#177; s )</td><td align="center" valign="middle" >29.96 &#177; 19.71</td><td align="center" valign="middle" >7.35 &#177; 7.31</td><td align="center" valign="middle" >−12.975</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >面罩/鼻导管吸氧时间(d, x &#175; &#177; s )</td><td align="center" valign="middle" >22.16 &#177; 15.13</td><td align="center" valign="middle" >4.53 &#177; 6.83</td><td align="center" valign="middle" >−13.048</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >吸氧浓度 ≥ 30% (n, %)</td><td align="center" valign="middle" >79 (59.0)</td><td align="center" valign="middle" >89 (22.4)</td><td align="center" valign="middle" >62.129</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >输血(n, %)</td><td align="center" valign="middle" >119 (88.8)</td><td align="center" valign="middle" >202 (50.8)</td><td align="center" valign="middle" >60.656</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >输血次数(n, x &#175; &#177; s )</td><td align="center" valign="middle" >3.61 &#177; 2.95</td><td align="center" valign="middle" >1.18 &#177; 1.60</td><td align="center" valign="middle" >−9.129</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >体质量每日增长(g/d, x &#175; &#177; s )</td><td align="center" valign="middle" >12.98 &#177; 5.53</td><td align="center" valign="middle" >16.83 &#177; 5.44</td><td align="center" valign="middle" >7.065</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >总住院时间(d, x &#175; &#177; s )</td><td align="center" valign="middle" >72.69 &#177; 20.47</td><td align="center" valign="middle" >48.17 &#177; 13.04</td><td align="center" valign="middle" >−13.008</td><td align="center" valign="middle" >&lt;0.001</td></tr></tbody></table></table-wrap><p>表2. BPD组与非BPD组早产儿围生期临床资料比较</p><p>注：<sup>*</sup>PS：肺表面活性物质。</p></sec><sec id="s5_3"><title>3.3. BPD组与非BPD组临床并发症的发生情况比较分析</title><p>两组临床并发症的发生情况比较发现：BPD的发生与新生儿肺炎、败血症、NRDS、PDA、早产儿脑损伤、ROP、代谢性骨病、胆汁淤积、肺动脉高压等疾病的发生具有统计学关联(P均&lt;0.05)；而与NEC无关(P &gt; 0.05)；见表3。</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Comparison of incidence of clinical complications between BPD group and non-BPD grou</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >项目</th><th align="center" valign="middle" >例数</th><th align="center" valign="middle" >BPD组</th><th align="center" valign="middle" >非BPD组</th><th align="center" valign="middle" >χ<sup>2</sup></th><th align="center" valign="middle" >P</th></tr></thead><tr><td align="center" valign="middle" >新生儿肺炎(n, %)</td><td align="center" valign="middle" >176</td><td align="center" valign="middle" >77 (44.3)</td><td align="center" valign="middle" >99 (24.9)</td><td align="center" valign="middle" >48.091</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >败血症(n, %)</td><td align="center" valign="middle" >63</td><td align="center" valign="middle" >25 (18.7)</td><td align="center" valign="middle" >38 (9.5)</td><td align="center" valign="middle" >7.968</td><td align="center" valign="middle" >0.005</td></tr><tr><td align="center" valign="middle" >NRDS<sup>1</sup> (n, %)</td><td align="center" valign="middle" >426</td><td align="center" valign="middle" >120 (89.6)</td><td align="center" valign="middle" >306 (76.9)</td><td align="center" valign="middle" >7.472</td><td align="center" valign="middle" >0.001</td></tr><tr><td align="center" valign="middle" >PDA<sup>2</sup> (n, %)</td><td align="center" valign="middle" >164</td><td align="center" valign="middle" >64 (47.8)</td><td align="center" valign="middle" >100 (25.1)</td><td align="center" valign="middle" >24.087</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >早产儿脑损伤(n, %)</td><td align="center" valign="middle" >85</td><td align="center" valign="middle" >33 (24.6)</td><td align="center" valign="middle" >52 (13.1)</td><td align="center" valign="middle" >9.982</td><td align="center" valign="middle" >0.002</td></tr><tr><td align="center" valign="middle" >ROP<sup>3</sup> (n, %)</td><td align="center" valign="middle" >74</td><td align="center" valign="middle" >47 (35.1)</td><td align="center" valign="middle" >27 (6.8)</td><td align="center" valign="middle" >67.002</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >NEC<sup>4</sup> (n, %)</td><td align="center" valign="middle" >65</td><td align="center" valign="middle" >16 (11.9)</td><td align="center" valign="middle" >49 (12.3)</td><td align="center" valign="middle" >0.013</td><td align="center" valign="middle" >0.910</td></tr><tr><td align="center" valign="middle" >代谢性骨病(n, %)</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >19 (14.2)</td><td align="center" valign="middle" >20 (5.0)</td><td align="center" valign="middle" >12.365</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >胆汁淤积(n, %)</td><td align="center" valign="middle" >62</td><td align="center" valign="middle" >25 (15.6)</td><td align="center" valign="middle" >37 (9.3)</td><td align="center" valign="middle" >8.531</td><td align="center" valign="middle" >0.003</td></tr><tr><td align="center" valign="middle" >肺动脉高压(n, %)</td><td align="center" valign="middle" >33</td><td align="center" valign="middle" >15 (11.2)</td><td align="center" valign="middle" >18 (4.5)</td><td align="center" valign="middle" >7.669</td><td align="center" valign="middle" >0.006</td></tr></tbody></table></table-wrap><p>表3. BPD组与非BPD组临床并发症的发生情况比较</p><p>注：1. NRDS：新生儿呼吸窘迫综合征；2. PDA：动脉导管未闭；3. ROP：早产儿视网膜病变；4. NEC：新生儿坏死性小肠结肠炎。</p></sec></sec><sec id="s6"><title>4. 讨论</title><p>BPD早在1967年由Northway [<xref ref-type="bibr" rid="hanspub.35273-ref5">5</xref>] 等首次提出并命名，指继发于严重的NRDS，因氧中毒、气压伤及容量伤致肺损伤，且持续用氧时间至少超过28天。随医疗水平的提高，BPD的定义已由“经典型BPD”演变为“新型BPD”。新型BPD指出生时无或仅有轻型NRDS，具有长期赖氧、缺氧临床表现和肺泡结构简单化的病理特点。2018年6月美国国家儿童健康与人类发展研究所(NICHD)举办的BPD研讨会对BPD的定义做了进一步的改进，建议胎龄 &lt; 32周具有持续性肺病(影像学确诊为肺实质性病变)的早产儿在矫正胎龄36周时仍有赖氧现象可确诊为BPD；严重程度取决于连确诊时连续3天维持动脉氧饱和度在90%~95%之间所需FiO<sub>2</sub>范围/氧气水平/氧浓度等指标 [<xref ref-type="bibr" rid="hanspub.35273-ref4">4</xref>]，并采用I、II、III级描述，III级是指最严重BPD形式。BPD发病机制尚未阐明，缺乏有效治疗方法，仍是新生儿科医生面临的临床挑战之一。</p><p>本研究表明，胎龄 &lt; 32周早产儿BPD的发生率为25.2%，且胎龄和出生体重与BPD的发生相关，随胎龄和出生体重的增长，BPD的发生率随之降低。NICHD新生儿研究网络2001年统计的数据显示，低出生体重是BPD的危险因素，其中，极低出生体重儿BPD的发生率40% [<xref ref-type="bibr" rid="hanspub.35273-ref6">6</xref>]；而Stoll B. J. [<xref ref-type="bibr" rid="hanspub.35273-ref7">7</xref>] 等人的研究显示胎龄越小，BPD的发生率越高，与我们的研究结果相仿。这是因胎儿肺发育在24~38周为囊状期、36周~8岁为肺泡期，早产儿的肺发育成熟多于出生后进行，易受各种不利因素的打击致肺损伤、肺成熟受阻 [<xref ref-type="bibr" rid="hanspub.35273-ref8">8</xref>]。因此，预防早产的发生是预防BPD发生的最根本措施之一。</p><p>BPD的产前预防主要针对避免或减少影响BPD发生的各种危险因素。本研究显示，孕母接受IVF-ET或顺产的早产儿而更易发生BPD (P均&lt;0.05)。这是因为IVF-ET是影响胎儿早产的危险因素 [<xref ref-type="bibr" rid="hanspub.35273-ref9">9</xref>]，而及时剖宫产解除了影响BPD发生产前危险因素。本文中，胎膜早破时间 &gt; 18 h、羊水污染是影响发生BPD的高危因素(P均&lt;0.05)。而胎膜早破时间 &gt; 18 h、羊水污染均是影响胎儿发生宫内感染的危险因素，可致羊水、胎膜和胎盘感染，特别是致绒毛膜羊膜炎后可使胎儿暴露于炎性因子和介质中导致胎儿肺损伤 [<xref ref-type="bibr" rid="hanspub.35273-ref10">10</xref>]，是BPD发生的危险因素 [<xref ref-type="bibr" rid="hanspub.35273-ref11">11</xref>]。Tanaka S. [<xref ref-type="bibr" rid="hanspub.35273-ref12">12</xref>] 等研究显示，胎膜早破的孕母产前应用氨苄西林–舒巴坦和阿奇霉素可降低中重度早产儿BPD的发生率。此外，产前应用糖皮质激素可促进PS分泌，并促进肺发育 [<xref ref-type="bibr" rid="hanspub.35273-ref13">13</xref>]，还可降低早产及早产儿RDS、脑室内出血、NEC和早期呼吸系统疾病的发生 [<xref ref-type="bibr" rid="hanspub.35273-ref14">14</xref>]。因此，关于BPD的产前预防主要是针对抗炎治疗策略，主要包含产前抗生素的应用和产前糖皮质激素的应用 [<xref ref-type="bibr" rid="hanspub.35273-ref15">15</xref>]。</p><p>研究表明，1分钟Apgar评分、5分钟Apgar评分与BPD的发生相关(P均&lt;0.05)，提示围生期窒息是影响BPD的高危因素。窒息可致早产儿肺组织缺氧、肺循环受阻，促进BPD的发展。因此，及时进行有效的产房复苏可缩短缺血缺氧时件，减少BPD的发生。本文中，BPD组单剂PS的应用率和多剂PS的应用率均高于非BPD组(P &lt; 0.05)。外源性PS的补充主要用于NRDS的治疗，提示有NRDS的早产儿易发生BPD。本研究亦证实NRDS与BPD相关(P &lt; 0.05)。因为，补充外源性PS时采用气管插管连接间歇性正压通气等有创操作过程增加了肺损伤有关。但IN-SUR-E、LISA等新型PS给药方式，可降低BPD的发生率 [<xref ref-type="bibr" rid="hanspub.35273-ref13">13</xref>]。因此，有经验的临床医生应尽量选择此类PS给药方式以预防BPD的发生。</p><p>目前公认的是BPD的发生与高浓度氧疗、长时间的机械通气等早产儿呼吸治疗措施密切相关。本研究示，侵入性有创机械通气时间、无创通气时间、面罩/鼻导管吸氧时间及吸氧浓度 ≥ 40%等呼吸治疗因素均为BPD发生的高危因素(P均&lt;0.05)。有研究示显示，机械通气时间越长、氧浓度越高，早产儿BPD的程度越重 [<xref ref-type="bibr" rid="hanspub.35273-ref16">16</xref>]。长时间的机械通气，特别是早产儿生命早期应用侵入性有创机械通气可通过所产生的容量伤、气压伤可直接造成肺损伤。高氧即可直接损伤肺毛细血管内皮细胞和肺泡上皮细胞，亦可诱发活性氧自由基、炎性介质等间接导致肺损伤 [<xref ref-type="bibr" rid="hanspub.35273-ref17">17</xref>]。研究表明，膈神经调节辅助通气 [<xref ref-type="bibr" rid="hanspub.35273-ref18">18</xref>]、新型无创通气模式的选择以及保护性通气策略、允许性高碳酸血症的应用亦可降低BPD的发生。所以，从呼吸管理角度，BPD的防治应当尽量降低吸氧浓度及缩短呼吸机应用时间，并尽量减少有创性的操作。</p><p>本研究还显示，BPD与新生儿肺炎、败血症等疾病具有统计学关联(P均&lt;0.05)，但与新NEC无关(P &gt; 0.05)。BPD早产儿较非BPD早产儿胎龄更小、体重更低且免疫功能发育不成熟，对病原微生物的抵抗能力弱，易发生败血症、肺炎的感染性疾病。感染可诱发的炎性因子风暴，又可导致早产儿肺组织损伤 [<xref ref-type="bibr" rid="hanspub.35273-ref19">19</xref>]。此外，本研究中，贫血的发生、应用输血和输血次数均与BPD的发生相关。Jun Duan [<xref ref-type="bibr" rid="hanspub.35273-ref20">20</xref>] 等研究亦表明早期贫血、输血次数与BPD的发生相关，并认为低血红蛋白降低了全身输送氧气的能力诱发的高代谢和高碳酸血症，及输血后增加的铁储备所诱发的氧自由基均会对未成熟的肺造成损伤。本研究中，PDA与BPD的发生相关(P &lt; 0.05)。在现有的流行病学临床队列研究中，PDA一直与BPD的发展相关 [<xref ref-type="bibr" rid="hanspub.35273-ref4">4</xref>]，但其在BPD发展中的作用机制并不明且未在人体研究中找到直接证据。本研究结果还表明，BPD的发展与肺动脉高压相关(P &lt; 0.05)。长期以来，肺动脉高压和肺血管疾病均被视为是导致BPD早产儿预后不良的重要原因 [<xref ref-type="bibr" rid="hanspub.35273-ref5">5</xref>]。早产儿肺损伤后肺血管异常发育和重建的结局是“新型BPD”的主要病理特点是肺泡结构简单化、肺血管发育受阻，同时也是BPD合并肺动脉高压的可能病理基础 [<xref ref-type="bibr" rid="hanspub.35273-ref21">21</xref>]。所以，对于中重度的早产儿应定期进行肺动脉高压的监测和筛查，以期早发现、早防治及改善BPD早产儿的预后。此外，本研究还表表明，BPD与早产儿脑损伤、ROP、代谢性骨病、胆汁淤积等肺外疾病相关，这与国内外的临床研究相仿 [<xref ref-type="bibr" rid="hanspub.35273-ref22">22</xref>] [<xref ref-type="bibr" rid="hanspub.35273-ref23">23</xref>] [<xref ref-type="bibr" rid="hanspub.35273-ref24">24</xref>]。这可能与BPD早产儿本身胎龄小、出生体重低有关。BPD与上述肺外疾病均为多种因素共同作用的结局，其中部分因素或为共同高危因素，或者BPD的某些治疗措施是影响肺外疾病的危险因素。总之，BPD合并肺外疾病的早产儿多预后较差、生活质量欠佳。因此，对于发生BPD的早产儿应积极预防肺外疾病的发生，改善预后和生活质量。</p></sec><sec id="s7"><title>5. 结论</title><p>综上所述，BPD是多种因素综合作用的慢性肺病，小胎龄、低体重是影响BPD发生的最根本的因素，胎龄 &lt; 32周早产儿BPD的发生与多种孕母产前因素、围生期因素和早产儿生的治疗因素相关，且住院期间更易并发各种心肺并发症和肺外并发症，预后和生活质量差。避免早产、减少孕母产前感染及早产儿生后感染、缩短机械通气和用氧时间、降低用氧浓度和积极防治并发症，以期预防BPD的发生并改善预后。</p></sec><sec id="s8"><title>本研究局限性</title><p>本研究为回顾性研究，尚存在一定的局限性。研究为单中心研究，研究样本量较小，证据等级欠佳，我们将继续收集相关临床资料以增加样本量，并寻求多中心合作。且本研究选取研究对象的资料仅为院内资料，未进行远期并发症及预后的观察，下一步我们见进行长期随访的研究。</p></sec><sec id="s9"><title>文章引用</title><p>李丽丽,李 瑞,曾月瑶,刘冬云. 胎龄 &lt; 32周早产儿支气管肺发育不良临床危险因素及并发症的分析与防治策略Analysis ofClinical Risk Factors, Complications and Prevention Strategies for Bronchopulmonary Dysplasia in Preterm Infants with Gestational Age &lt; 32 Weeks[J]. 临床医学进展, 2020, 10(04): 587-594. https://doi.org/10.12677/ACM.2020.104092</p></sec><sec id="s10"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.35273-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Horbar, J.D., Edwards, E.M., Greenberg, L.T., et al. (2017) Variation in Performance of Neonatal Intensive Care Units in the United States. JAMA Pediatrics, 171, e164396. &lt;br&gt;https://doi.org/10.1001/jamapediatrics.2016.4396</mixed-citation></ref><ref id="hanspub.35273-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Chen, D., Chen, J., Cui, N., et al. (2019) Respiratory Morbidity and Lung Function Analysis during the First 36 Months of Life in Infants with Bronchopulmonary Dysplasia (BPD). Frontiers in Pediatrics, 7, 540.  
&lt;br&gt;https://doi.org/10.3389/fped.2019.00540</mixed-citation></ref><ref id="hanspub.35273-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Sillers, L., Alexiou, S. and Jensen, E.A. (2020) Lifelong Pulmonary Sequelae of Bronchopulmonary Dysplasia. Current Opinion in Pediatrics, 32, 252-260. &lt;br&gt;https://doi.org/10.1097/MOP.0000000000000884</mixed-citation></ref><ref id="hanspub.35273-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Higgins, R.D., Jobe, A.H., Koso-Thomas, M., et al. (2018) Bronchopulmonary Dysplasia: Executive Summary of a Workshop. The Journal of Pediatrics, 197, 300-308. &lt;br&gt;https://doi.org/10.1016/j.jpeds.2018.01.043</mixed-citation></ref><ref id="hanspub.35273-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Northway, W.H., Rosan, R.C. and Porter, D.Y. (1967) Pulmonary Disease Following Respirator Therapy of Hyaline-Membrane Disease. Bronchopulmonary Dysplasia. The New England Journal of Medicine, 276, 357-368.  
&lt;br&gt;https://doi.org/10.1056/NEJM196702162760701</mixed-citation></ref><ref id="hanspub.35273-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Lemons, J.A., Bauer, C.R., Oh, W., et al. (2001) Very Low Birth Weight Outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics, 107, E1. &lt;br&gt;https://doi.org/10.1542/peds.107.1.e1</mixed-citation></ref><ref id="hanspub.35273-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Stoll, B.J., Hansen, N.I., Bell, E.F., et al. (2015) Trends in Care Prac-tices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. JAMA, 314, 1039-1051. &lt;br&gt;https://doi.org/10.1001/jama.2015.10244</mixed-citation></ref><ref id="hanspub.35273-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">O’Reilly, M., Sozo, F. and Harding, R. (2013) Impact of Preterm Birth and Bronchopulmonary Dysplasia on the Developing Lung: Long-Term Consequences for Respiratory Health. Clinical and Experimental Pharmacology and Physiology, 40, 765-773. &lt;br&gt;https://doi.org/10.1111/1440-1681.12068</mixed-citation></ref><ref id="hanspub.35273-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">赵西, 阿丽米热麦麦提, 朱梦兰, 等. 体外受精-胚胎移植术后单胎妊娠早产相关因素的临床研究[J]. 中华产科急救电子杂志, 2019, 8(3): 169-173.</mixed-citation></ref><ref id="hanspub.35273-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Choi, C.W. (2017) Chorioamnionitis: Is a Major Player in the Development of Bronchopulmonary Dysplasia? Korean Journal of Pediatrics, 60, 203-207. &lt;br&gt;https://doi.org/10.3345/kjp.2017.60.7.203</mixed-citation></ref><ref id="hanspub.35273-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Mir, I.N., Chalak, L.F., Brown, L.S., et al. (2019) Impact of Multiple Placental Pathologies on Neonatal Death, Bronchopulmonary Dysplasia, and Neurodevelopmental Impairment in Preterm Infants. Pediatric Research, 87, 885-891.  
&lt;br&gt;https://doi.org/10.1038/s41390-019-0715-y</mixed-citation></ref><ref id="hanspub.35273-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Tanaka, S., Tsumura, K., Nakura, Y., et al. (2019) New Antibiotic Regimen for Preterm Premature Rupture of Membrane Reduces the Incidence of Bronchopulmonary Dysplasia. Journal of Obstetrics &amp; Gynaecology Research, 45, 967-973. &lt;br&gt;https://doi.org/10.1111/jog.13903</mixed-citation></ref><ref id="hanspub.35273-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">崔红, 王新宝. 支气管肺发育不良的预防和治疗[J]. 中国儿童保健杂志, 2019(10): 1050-1053.</mixed-citation></ref><ref id="hanspub.35273-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Sweet, D.G., Carnielli, V., Greisen, G., et al. (2019) European Consensus Guidelines on the Management of Respiratory Distress Syndrome—2019 Update. Neonatology, 115, 432-450. &lt;br&gt;https://doi.org/10.1159/000499361</mixed-citation></ref><ref id="hanspub.35273-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">薛辛东, 杨海萍. 早产儿支气管肺发育不良防治及管理的新认识[J]. 中华妇幼临床医学杂志(电子版), 2014(1): 5-8.</mixed-citation></ref><ref id="hanspub.35273-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">王玉光, 刘冬云, 姜红, 等. 早产儿中重度支气管肺发育不良临床高危因素分析[J]. 中国综合临床, 2017, 33(6): 511-515.</mixed-citation></ref><ref id="hanspub.35273-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Cayabyab, R., Arora, V., Wertheimer, F., et al. (2016) Graded Oxygen Saturation Targets and Retinopathy of Prematurity in Extremely Preterm Infants. Pediatric Research, 80, 401-406. &lt;br&gt;https://doi.org/10.1038/pr.2016.98</mixed-citation></ref><ref id="hanspub.35273-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">McKinney, R.L., Keszler, M., Truog, W.E., et al. (2020) Multicenter Experience with Neurally Adjusted Ventilatory Assist in Infants with Severe Bronchopulmonary Dysplasia. American Journal of Perinatology.  
&lt;br&gt;https://doi.org/10.1055/s-0040-1708559</mixed-citation></ref><ref id="hanspub.35273-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Glaser, K., Gradzka-Luczewska, A., Szymankiewicz-Breborowicz, M., et al. (2019) Perinatal Ureaplasma Exposure Is Associated with Increased Risk of Late Onset Sepsis and Imbalanced Inflammation in Preterm Infants and May Add to Lung Injury. Frontiers in Cellular and Infection Microbiology, 9, 68. &lt;br&gt;https://doi.org/10.3389/fcimb.2019.00068</mixed-citation></ref><ref id="hanspub.35273-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Duan, J., Kong, X., Li, Q., et al. (2016) Association between Anemia and Bronchopulmonary Dysplasia in Preterm Infants. Scientific Reports, 6, Article No. 22717. &lt;br&gt;https://doi.org/10.1038/srep22717</mixed-citation></ref><ref id="hanspub.35273-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Du, Y., Zhou, J.G. and Chen, C. (2020) Research Progress in Diagnosis and Treatment of Pulmonary Hypertension Associated with Bronchopulmonary Dysplasia. Chinese Journal of Pediatrics, 58, 162-165.</mixed-citation></ref><ref id="hanspub.35273-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">侯阿娜, 张妮, 富建华, 等. 支气管肺发育不良早产儿早期肺外合并症的临床分析[J]. 中国小儿急救医学, 2017, 24(4): 273-277.</mixed-citation></ref><ref id="hanspub.35273-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Podraza, W., Michalczuk, B., Jezierska, K., et al. (2018) Correlation of Retinopathy of Prematurity with Bronchopulmonary Dysplasia. Open Medicine (Wars), 13, 67-73. &lt;br&gt;https://doi.org/10.1515/med-2018-0012</mixed-citation></ref><ref id="hanspub.35273-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Bauer, S.E., Schneider, L., Lynch, S.K., et al. (2020) Factors Asso-ciated with Neurodevelopmental Impairment in Bronchopulmonary Dysplasia. The Journal of Pediatrics, 218, 22-27.e2.</mixed-citation></ref></ref-list></back></article>